» Authors » Terry Jacot

Terry Jacot

Explore the profile of Terry Jacot including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 31
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mauck C, Thurman A, Jensen J, Schreiber C, Baker J, Hou M, et al.
Contraception . 2024 Mar; 135:110440. PMID: 38552818
Objectives: Evaluate the safety of Ovaprene, an investigational nonhormonal vaginal contraceptive designed for monthly use. Study Design: Open-label, multicenter study enrolling heterosexually-active women with previous permanent contraception who underwent assessments...
2.
Thurman A, Brache V, Cochon L, Ouattara L, Chandra N, Jacot T, et al.
PLoS One . 2022 Oct; 17(10):e0275794. PMID: 36215267
Multipurpose prevention technologies (MPTs), which prevent sexually transmitted infection(s) and unintended pregnancy, are highly desirable to women. In this randomized, placebo-controlled, phase I study, women used a placebo or tenofovir...
3.
Thurman A, Ravel J, Gajer P, Marzinke M, Ouattara L, Jacot T, et al.
Front Cell Infect Microbiol . 2022 Mar; 12:799501. PMID: 35350436
Background: A relationship between the vaginal microbiota and tenofovir (TFV) concentrations and activity after topical administration has been previously reported. Objective: CONRAD A15-138 was a randomized, placebo-controlled Phase I study...
4.
Sabouni R, Archer D, Jacot T
Reprod Sci . 2021 Feb; 28(7):1974-1980. PMID: 33559058
Drospirenone (DRSP) is a fourth-generation progestin that interacts with the progesterone receptor (PR) and androgen receptor (AR) in addition to uniquely interacting to the mineralocorticoid receptor (MR). The known effects...
5.
Thurman A, Jacot T, Melendez J, Kimble T, Snead M, Jamshidi R, et al.
Contraception . 2016 Jun; 94(5):512-520. PMID: 27259675
Objective: The primary objective of this pilot study is to determine and compare the residence time in the vagina of biomarkers of semen exposure for up to 15 days post...
6.
Pakrashi T, Taylor J, Nelson A, Archer D, Jacot T
Reprod Sci . 2016 May; 23(11):1536-1541. PMID: 27130232
Objective: The levonorgestrel-releasing intrauterine system is considered a highly effective treatment of heavy menstrual bleeding (HMB). While LNG has established effects on the stromal and glandular compartments of the endometrial...